Days Inventory is also known as Days Sales of Inventory (DSI). Puma Biotechnology's Average Total Inventories for the
three
months ended in Dec. 2023 was $6.4 Mil. Puma Biotechnology's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $24.3 Mil.
Hence, Puma Biotechnology's Days Inventory for the
three
months ended in Dec. 2023 was 23.93.
The historical rank and industry rank for Puma Biotechnology's Days Inventory or its related term are showing as below:
PBYI'
s Days Inventory Range Over the Past 10 Years
Min: 24.53 Med: 30.7 Max: 132.91
Current: 33.55
During the past 13 years, Puma Biotechnology's highest Days Inventory was 132.91. The lowest was 24.53. And the median was 30.70.
PBYI's Days Inventory is ranked better than 90.76% of 649
companies
in the Biotechnology industry
Industry Median: 191.36
vs PBYI: 33.55
Puma Biotechnology's Days Inventory
declined
from Dec. 2022 (27.04) to Dec. 2023 (23.93).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Puma Biotechnology's Inventory Turnover for the
three
months ended in Dec. 2023 was 3.81.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Puma Biotechnology's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.09.
Puma Biotechnology Days Inventory Historical Data
The historical data trend for Puma Biotechnology's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Puma Biotechnology's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Puma Biotechnology Days Inventory Distribution
For the Biotechnology industry and Healthcare sector, Puma Biotechnology's Days Inventory distribution charts can be found below:
* The bar in red indicates where Puma Biotechnology's Days Inventory falls into.
Puma Biotechnology Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Puma Biotechnology's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Puma Biotechnology (NAS:PBYI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Puma Biotechnology's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Puma Biotechnology's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Puma Biotechnology Days Inventory Related Terms
Thank you for viewing the detailed overview of Puma Biotechnology's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Puma Biotechnology (Puma Biotechnology) Business Description
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Neratinib, oral was approved by the U.S. FDA in 2017 for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, following adjuvant trastuzumab-based therapy, and is marketed in the US as NERLYNX.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBYI has been successfully added to your 